Your source for the latest content and news from BiOrion:


BiOrion concluded investment by Carduso Capital

BiOrion Technologies BV has raised funding from Carduso Capital for its clinical validation program in fibrosis. BiOrion Technologies BV (BiOrion), a biopharmaceutical drug discovery company, develops products for the diagnosis and treatment of fibrosis. Fibrosis is a...

read more